Hepatic organic ion uptake transporters (Hepatic SLC transporters)

Hepatic organic ion uptake transporters are a group of membrane-bound proteins, primarily belonging to the Solute Carrier (SLC) superfamily, located on the basolateral (sinusoidal) membrane of hepatocytes (International Transporter Consortium, Nature Reviews Drug Discovery, 2010). They play a critical role in the first step of hepatic clearance by mediating the entry of endogenous compounds—such as bile acids, bilirubin, and thyroid hormones—and exogenous substances, including a wide array of drugs, from the blood into the liver (FDA Guidance, 2020). Key members include the Organic Anion Transporting Polypeptides (OATP1B1, OATP1B3, OATP2B1), Organic Cation Transporter 1 (OCT1), and Organic Anion Transporters (OAT2, OAT7) (UniProt, 2023). These transporters are major determinants of the pharmacokinetics, efficacy, and safety profiles of many therapeutic agents, particularly statins and metformin (PubMed, 2021). Inhibition of these transporters by co-administered drugs is a frequent cause of clinically significant drug-drug interactions, often leading to increased plasma concentrations and potential toxicity (EMA Guideline, 2012). Genetic polymorphisms in these transporters, such as the SLCO1B1*5 allele, can significantly alter drug response and susceptibility to adverse effects like statin-induced myopathy (Nature Reviews Drug Discovery, 2010). Understanding their function is essential for predicting drug disposition and managing patient safety in polypharmacy scenarios (StatPearls, 2023).

Other names

Hepatic uptake transportersLiver solute carrier transportersOrganic anion transporting polypeptides (OATPs)Organic cation transporters (OCTs)Organic anion transporters (OATs)

Facilitated diffusion and active transport of organic anions and cations into hepatocytes; drugs act as substrates for clearance or as inhibitors leading to drug-drug interactions (FDA, 2020).